Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity

dc.contributor.authorHong, Gloria J.
dc.contributor.authorStinnett, Sandra S.
dc.contributor.authorFreedman, Sharon F.
dc.contributor.authorWallace, David K.
dc.contributor.authorPrakalapakorn, S. Grace
dc.contributor.departmentOphthalmology, School of Medicineen_US
dc.date.accessioned2021-10-14T16:58:32Z
dc.date.available2021-10-14T16:58:32Z
dc.date.issued2021-05-06
dc.description.abstractGuidelines on managing infants after initial anti-vascular endothelial growth factor (VEGF) treatment (eg, bevacizumab) for retinopathy of prematurity (ROP) are limited. We found that following initial bevacizumab treatment for ROP, prophylactically lasering infant eyes before hospital discharge reduced the number and duration of outpatient ROP screening examinations compared with following infants, per current United States (US) ROP screening guidelines.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationHong, G. J., Stinnett, S. S., Freedman, S. F., Wallace, D. K., & Prakalapakorn, S. G. (2021). Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity. Journal of American Association for Pediatric Ophthalmology and Strabismus. https://doi.org/10.1016/j.jaapos.2021.02.002en_US
dc.identifier.issn1091-8531en_US
dc.identifier.urihttps://hdl.handle.net/1805/26779
dc.language.isoenen_US
dc.publisherScience Directen_US
dc.relation.isversionof10.1016/j.jaapos.2021.02.002en_US
dc.relation.journalJournal of American Association for Pediatric Ophthalmology and Strabismusen_US
dc.rightsIUPUI Open Access Policyen_US
dc.sourceAuthoren_US
dc.subjectProphylactic laseren_US
dc.subjectbevacizumab treatmenten_US
dc.subjectretinopathy of prematurityen_US
dc.titleProphylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurityen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Hong2021Prophylactic-AAM.pdf
Size:
1.74 MB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: